National Asset Management, Inc. Merck & Co., Inc. Transaction History

National Asset Management, Inc.

$4.29 Billion
Q1 2024

A detailed history of National Asset Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, National Asset Management, Inc. holds 162,575 shares of MRK stock, worth $20.1 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

162,575

Previous 146,629 10.88%

Holding current value

$20.1 Million

Previous $16 Million 34.19%

% of portfolio

0.5%

Previous 0.44%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	BUY	$113.24 - $131.95 $1.81 Million - $2.1 Million	15,946 Added 10.88%	162,575 $21.5 Million
Q4 2023 Mar 15, 2024	SELL	$100.18 - $109.02 $1.6 Million - $1.74 Million	-15,946 Reduced 9.81%	146,629 $16 Million
Q3 2023 Dec 01, 2023	SELL	$102.95 - $114.33 $671,131 - $745,317	-6,519 Reduced 3.86%	162,575 $16.7 Million
Q2 2023 Jul 27, 2023	SELL	$108.61 - $118.38 $1 Million - $1.09 Million	-9,208 Reduced 5.16%	169,094 $19.5 Million
Q1 2023 May 17, 2023	SELL	$102.94 - $114.86 $1.41 Million - $1.57 Million	-13,709 Reduced 7.14%	178,302 $19 Million

Q4 2022 Mar 15, 2023	SELL	$87.44 - $112.11 $4,984 - $6,390	-57 Reduced 0.03%	192,011 $21.3 Million
Q4 2022 Feb 21, 2023	BUY	$87.44 - $112.11 $25,270 - $32,399	289 Added 0.15%	192,068 $21.3 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $6.53 Million - $7.34 Million	77,268 Added 67.48%	191,779 $16.5 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $658,151 - $746,047	7,883 Added 7.39%	114,511 $10.4 Million
Q1 2022 May 02, 2022	SELL	$73.51 - $82.4 $185,980 - $208,472	-2,530 Reduced 2.32%	106,628 $8.75 Million
Q4 2021 Jan 28, 2022	BUY	$72.28 - $90.54 $253,991 - $318,157	3,514 Added 3.33%	109,158 $8.37 Million
Q3 2021 Nov 16, 2021	BUY	$71.68 - $78.83 $290,877 - $319,892	4,058 Added 3.99%	105,644 $7.94 Million
Q2 2021 Aug 10, 2021	BUY	$70.31 - $77.77 $263,732 - $291,715	3,751 Added 3.83%	101,586 $7.9 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $2.1 Million - $2.48 Million	30,538 Added 45.38%	97,835 $7.56 Million
Q4 2020 Feb 04, 2021	SELL	$71.77 - $79.65 $1.61 Million - $1.78 Million	-22,374 Reduced 24.95%	67,297 $5.51 Million
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $853,059 - $966,948	11,657 Added 14.94%	89,671 $7.3 Million
Q2 2020 Jul 31, 2020	BUY	$70.42 - $80.13 $118,728 - $135,099	1,686 Added 2.21%	78,014 $6.03 Million
Q1 2020 May 06, 2020	BUY	$63.36 - $87.82 $732,124 - $1.01 Million	11,555 Added 17.84%	76,328 $5.88 Million
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $844,070 - $952,435	10,880 Added 20.19%	64,773 $5.89 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $405,962 - $442,514	5,336 Added 10.99%	53,893 $4.54 Million
Q2 2019 Aug 05, 2019	BUY	$69.84 - $81.59 $244,300 - $285,401	3,498 Added 7.76%	48,557 $4.07 Million
Q1 2019 May 08, 2019	BUY	$69.58 - $79.36 $242,903 - $277,045	3,491 Added 8.4%	45,059 $3.75 Million
Q4 2018 Feb 08, 2019	BUY	$65.24 - $75.71 $150,182 - $174,284	2,302 Added 5.86%	41,568 $3.18 Million
Q3 2018 Nov 08, 2018	BUY	$57.69 - $67.84 $389,119 - $457,580	6,745 Added 20.74%	39,266 $2.79 Million
Q2 2018 Oct 05, 2018	SELL	$50.83 - $59.72 $174,702 - $205,257	-3,437 Reduced 9.56%	32,521 $1.98 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $575,491 - $668,884	-11,293 Reduced 23.9%	35,958 $1.96 Million
Q4 2017 Feb 15, 2018	SELL	$51.62 - $61.64 $146,600 - $175,057	-2,840 Reduced 5.67%	47,251 $2.66 Million
Q3 2017 Nov 13, 2017	SELL	$58.67 - $63.13 $8,917 - $9,595	-152 Reduced 0.3%	50,091 $3.21 Million
Q2 2017 Aug 15, 2017	BUY	N/A	50,243	50,243 $3.22 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account

National Asset Management, Inc. Merck & Co., Inc. Transaction History